News from Weill Cornell Medical College
Weill Cornell's Dr. John P. Leonard Leads National Cancer Institute's Alliance for Clinical Trials in Oncology Lymphoma Committee
May 16, 2013 Dr. John Leonard, an internationally-recognized hematology and oncology expert specializing in the treatment of lymphomas at Weill Cornell Medical College, has been named chair of the Lymphoma Committee for the prestigious National Cancer Institute-sponsored group, the Alliance for Clinical Trials in Oncology. Dr. Leonard is the associate dean for clinical research at Weill Cornell and director of the Joint Clinical Trials Office at Weill Cornell and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. [more]
More Press Releases
Researchers Discover Master Regulator That Drives Majority of Lymphoma
May 13, 2013 A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients.
May 13, 2013 A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients.
Cocaine Vaccine Passes Key Testing Hurdle
May 10, 2013 Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials.
May 10, 2013 Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials.
